These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 31028773)

  • 1. para-Trifluoromethyl-methcathinone is an allosteric modulator of the serotonin transporter.
    Niello M; Cintulova D; Hellsberg E; Jäntsch K; Holy M; Ayatollahi LH; Cozzi NV; Freissmuth M; Sandtner W; Ecker GF; Mihovilovic MD; Sitte HH
    Neuropharmacology; 2019 Dec; 161():107615. PubMed ID: 31028773
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quantitative structure-activity relationship analysis of the pharmacology of para-substituted methcathinone analogues.
    Bonano JS; Banks ML; Kolanos R; Sakloth F; Barnier ML; Glennon RA; Cozzi NV; Partilla JS; Baumann MH; Negus SS
    Br J Pharmacol; 2015 May; 172(10):2433-44. PubMed ID: 25438806
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Steric parameters, molecular modeling and hydropathic interaction analysis of the pharmacology of para-substituted methcathinone analogues.
    Sakloth F; Kolanos R; Mosier PD; Bonano JS; Banks ML; Partilla JS; Baumann MH; Negus SS; Glennon RA
    Br J Pharmacol; 2015 May; 172(9):2210-8. PubMed ID: 25522019
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacological examination of trifluoromethyl ring-substituted methcathinone analogs.
    Cozzi NV; Brandt SD; Daley PF; Partilla JS; Rothman RB; Tulzer A; Sitte HH; Baumann MH
    Eur J Pharmacol; 2013 Jan; 699(1-3):180-7. PubMed ID: 23178523
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Decoding the Structure of Abuse Potential for New Psychoactive Substances: Structure-Activity Relationships for Abuse-Related Effects of 4-Substituted Methcathinone Analogs.
    Negus SS; Banks ML
    Curr Top Behav Neurosci; 2017; 32():119-131. PubMed ID: 27696217
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Systematic Structure-Activity Studies on Selected 2-, 3-, and 4-Monosubstituted Synthetic Methcathinone Analogs as Monoamine Transporter Releasing Agents.
    Walther D; Shalabi AR; Baumann MH; Glennon RA
    ACS Chem Neurosci; 2019 Jan; 10(1):740-745. PubMed ID: 30354055
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 'Second-generation' mephedrone analogs, 4-MEC and 4-MePPP, differentially affect monoamine transporter function.
    Saha K; Partilla JS; Lehner KR; Seddik A; Stockner T; Holy M; Sandtner W; Ecker GF; Sitte HH; Baumann MH
    Neuropsychopharmacology; 2015 May; 40(6):1321-31. PubMed ID: 25502630
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Abuse-Related Neurochemical Effects of Para-Substituted Methcathinone Analogs in Rats: Microdialysis Studies of Nucleus Accumbens Dopamine and Serotonin.
    Suyama JA; Sakloth F; Kolanos R; Glennon RA; Lazenka MF; Negus SS; Banks ML
    J Pharmacol Exp Ther; 2016 Jan; 356(1):182-90. PubMed ID: 26645638
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Investigation of the Optical Isomers of Methcathinone, and Two Achiral Analogs, at Monoamine Transporters and in Intracranial Self-Stimulation Studies in Rats.
    Davies RA; Baird TR; Nguyen VT; Ruiz B; Sakloth F; Eltit JM; Negus SS; Glennon RA
    ACS Chem Neurosci; 2020 Jun; 11(12):1762-1769. PubMed ID: 32356961
    [TBL] [Abstract][Full Text] [Related]  

  • 10. α-PPP and its derivatives are selective partial releasers at the human norepinephrine transporter: A pharmacological characterization of interactions between pyrrolidinopropiophenones and high and low affinity monoamine transporters.
    Maier J; Rauter L; Rudin D; Niello M; Holy M; Schmid D; Wilson J; Blough BE; Gannon BM; Murnane KS; Sitte HH
    Neuropharmacology; 2021 Jun; 190():108570. PubMed ID: 33864800
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interrogating the Molecular Basis for Substrate Recognition in Serotonin and Dopamine Transporters with High-Affinity Substrate-Based Bivalent Ligands.
    Andersen J; Ladefoged LK; Kristensen TN; Munro L; Grouleff J; Stuhr-Hansen N; Kristensen AS; Schiøtt B; Strømgaard K
    ACS Chem Neurosci; 2016 Oct; 7(10):1406-1417. PubMed ID: 27425420
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MDMA (Ecstasy) and human dopamine, norepinephrine, and serotonin transporters: implications for MDMA-induced neurotoxicity and treatment.
    Verrico CD; Miller GM; Madras BK
    Psychopharmacology (Berl); 2007 Jan; 189(4):489-503. PubMed ID: 16220332
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Substituted methcathinones differ in transporter and receptor interactions.
    Eshleman AJ; Wolfrum KM; Hatfield MG; Johnson RA; Murphy KV; Janowsky A
    Biochem Pharmacol; 2013 Jun; 85(12):1803-15. PubMed ID: 23583454
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of an allosteric modulator of the serotonin transporter with novel mechanism of action.
    Kortagere S; Fontana AC; Rose DR; Mortensen OV
    Neuropharmacology; 2013 Sep; 72():282-90. PubMed ID: 23632081
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of N-Alkyl-4-Methylamphetamine Optical Isomers on Plasma Membrane Monoamine Transporters and Abuse-Related Behavior.
    Battisti UM; Sitta R; Harris A; Sakloth F; Walther D; Ruchala I; Negus SS; Baumann MH; Glennon RA; Eltit JM
    ACS Chem Neurosci; 2018 Jul; 9(7):1829-1839. PubMed ID: 29697951
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Functional characterization of N-octyl 4-methylamphetamine variants and related bivalent compounds at the dopamine and serotonin transporters using Ca
    Ruchala I; Battisti UM; Nguyen VT; Chen RY; Glennon RA; Eltit JM
    Toxicol Appl Pharmacol; 2021 May; 419():115513. PubMed ID: 33785354
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Methcathinone decreases dopamine transporter function: Role of protein kinase C.
    Magee CP; Le BD; Siripathane YH; Wilkins DG; Hanson GR; Fleckenstein AE
    J Neurochem; 2021 Oct; 159(1):116-127. PubMed ID: 34320222
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Elucidation of structural elements for selectivity across monoamine transporters: novel 2-[(diphenylmethyl)sulfinyl]acetamide (modafinil) analogues.
    Okunola-Bakare OM; Cao J; Kopajtic T; Katz JL; Loland CJ; Shi L; Newman AH
    J Med Chem; 2014 Feb; 57(3):1000-13. PubMed ID: 24494745
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Extracellular loops of the serotonin transporter act as a selectivity filter for drug binding.
    Esendir E; Burtscher V; Coleman JA; Zhu R; Gouaux E; Freissmuth M; Sandtner W
    J Biol Chem; 2021 Jul; 297(1):100863. PubMed ID: 34118233
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis of Novel Nicotinic Ligands with Multimodal Action: Targeting Acetylcholine α4β2, Dopamine and Serotonin Transporters.
    González-Gutiérrez JP; Pessoa-Mahana HA; Iturriaga-Vásquez PE; Reyes-Parada MI; Guerra-Díaz NE; Hodar-Salazar M; Viscarra F; Paillali P; Núñez-Vivanco G; Lorca-Carvajal MA; Mella-Raipán J; Zúñiga MC
    Molecules; 2019 Oct; 24(20):. PubMed ID: 31652614
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.